Vemurafenib as neoadjuvant treatment for unresectable regional metastatic melanoma

J Clin Oncol. 2013 Jun 1;31(16):e251-3. doi: 10.1200/JCO.2012.45.3845. Epub 2013 Apr 8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Indoles / therapeutic use*
  • Lymph Nodes / pathology*
  • Lymph Nodes / surgery
  • Lymphatic Metastasis
  • Magnetic Resonance Imaging
  • Male
  • Melanoma / drug therapy*
  • Melanoma / genetics
  • Melanoma / pathology
  • Melanoma / secondary
  • Melanoma / surgery*
  • Middle Aged
  • Multimodal Imaging
  • Mutation*
  • Neoadjuvant Therapy / methods*
  • Neoplasm Staging
  • Positron-Emission Tomography
  • Proto-Oncogene Proteins B-raf / drug effects
  • Proto-Oncogene Proteins B-raf / genetics*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / genetics
  • Skin Neoplasms / pathology
  • Skin Neoplasms / surgery*
  • Sulfonamides / therapeutic use*
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Vemurafenib

Substances

  • Antineoplastic Agents
  • Indoles
  • Sulfonamides
  • Vemurafenib
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf